Press Releases

07/08/10
iPierian Closes $22 Million Series B Financing Led By Google Ventures

06/15/10
iPierian to Present Data from Induced Pluripotent Stem Cell Program at ISSCR 8th Annual Meeting

04/29/10
iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming

02/22/10
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer

01/28/10
First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office

10/21/09
iPierian To Collaborate with Johns Hopkins University on $3.7 Million NIH Grand Opportunities Grant

09/01/09
iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer

08/06/09
iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board

07/08/09
iZumi Bio and Pierian Merge to form iPierian to Advance Cellular Reprogramming

06/11/09
iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

05/06/09
iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development

04/14/09
iZumi Bio and Kyoto University Form Collaboration to Advance Induced Pluripotent Stem Cell Technology

02/12/09
iZumi Bio. Inc., Appoints John Walker as Chief Executive Officer

08/06/08
iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough into Patient Benefits

06/16/08
The Gladstone Institutes and Izumi Bio Announce Broad Partnership in Regenerative Medicine And Cardiovascular Disease